References
- Le Coz J. Mesotherapie en Medecine Generale. Paris: Masson; 1996.
- Le Coz J. Traite de Mesotherapie. Paris: Masson; 2004.
- Rittes P. The use of phosphatidylcholine for correction of localized fat deposits. Aesth Plast Surg. 2003;27:315–18.
- Hexsel D, Serra M, Mazzuco R, Dal'Forno T, Zechmeister D. Phosphatidylcholine in the treatment of localized fat. J Drugs Dermatol. 2003;2:511–18.
- Lieber CS, De Carli LM, Mak KM, Kim CI, Leo MA. Attenuation of alcohol induced hepatic fibrosis and accelerates regression. J Hepatol. 1996;24:604–13.
- Khashimov KhA, Okur F, Orekhov AN, Kurdanov KhA, Tertov V. Effect of Lipostabil on cholesterol levels in atherosclerotic plaques of the human aorta and the aggregative capacity of thrombocytes (in vitro study). Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSR. 1988;11:95–98.
- Bobkova VI, Lokshina LI, Korsunskii VN, Tananova GV. Metabolic effects of lipostabil-forte. Kardiologiia. 1989;29:57–60.
- Ablon G, Rotunda A. Treatment of lower eyelid fat pads using phosphatidylcholine: clinical trial and review. Dermatol Surg. 2004;30(3):422–7.
- Rittes PG. The use of phosphatidylcholine for correction of lower lid bulging due to prominent fat pads. Dermatol Surg. 2001;27:391–92.
- Rotunda AM, Suzuki H, Moy RL, Kolodney MS. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg. 2004:1001–18.